scholarly journals Disseminated gonococcal infection: a potential marker of failing sexually transmitted infection control and prevention services

2021 ◽  
pp. sextrans-2021-055149
Author(s):  
Henna Patani ◽  
Adam Sukhija-Cohen ◽  
Jeffrey D Klausner ◽  
Whitney Engeran ◽  
Michael Weinstein
Keyword(s):  
Infection Control ◽  
Sexually Transmitted Infection ◽  
Gonococcal Infection ◽  
Transmitted Infection ◽  
Sexually Transmitted ◽  
Prevention Services ◽  
Potential Marker ◽  
Control And Prevention ◽  
Infection Control And Prevention

Review of Evidence and Recommendation for Human Papillomavirus (HPV) Vaccination of Canadian Males Over the Age of 26 Years

2020 ◽  
Vol 24 (3) ◽  
pp. 285-291 ◽  
Author(s):  
Alex Derstenfeld ◽  
Kyle Cullingham ◽  
Zhuo Cai Ran ◽  
Ivan V. Litvinov
Keyword(s):  
Human Papillomavirus ◽  
Sexually Transmitted Infection ◽  
Hpv Vaccine ◽  
Hpv Vaccination ◽  
Older Men ◽  
Hpv Infection ◽  
Transmitted Infection ◽  
Vaccination Programs ◽  
Sexually Transmitted ◽  
Control And Prevention

Human papillomavirus (HPV) remains the most common sexually transmitted infection with a lifetime incidence of over 75%. Based on US data from the Centers for Disease Control and Prevention (CDC), 64% of invasive HPV-associated cancers are attributable to HPV 16 or 18 (65% for females; 63% males) and may be prevented by vaccination with either the quadrivalent or nonavalent HPV vaccine. Public HPV vaccination programs are now the norm for women aged 9-45 years and men aged 9-26 years in Canada. Yet, only recently have guidelines begun to consider vaccination of men older than 26 years of age. There now exist compelling reasons to recommend vaccination against HPV amongst males >26 years of age. Recognizing that the risks posed by HPV infection persist beyond 26 years of age, that the vaccination of men aged 26-45 years with HPV vaccine confers immunogenicity at levels demonstrably efficacious against HPV-related diseases, and that the Food and Drug Administration recently expanded the HPV vaccination to include older men, it is argued that HPV vaccination in men older than 26 years of age should be routinely recommended.

scholarly journals 2021 CDC Update: Treatment and Complications of Sexually Transmitted Infections (STIs)

Venereology ◽  
2022 ◽  
Vol 1 (1) ◽  
pp. 23-46
Author(s):  
Benjamin Silverberg ◽  
Amy Moyers ◽  
Tate Hinkle ◽  
Roanna Kessler ◽  
Nancy G. Russell
Keyword(s):  
Primary Care ◽  
Disease Control ◽  
Community Health ◽  
Sexually Transmitted Infections ◽  
Sexually Transmitted Infection ◽  
Treatment Guidelines ◽  
Health Practice ◽  
Transmitted Infection ◽  
Sexually Transmitted ◽  
Control And Prevention

The Centers for Disease Control and Prevention (CDC) recently updated their Sexually-Transmitted Infection (STI) Treatment Guidelines with a revision to the approach to gonococcal infections in December 2020 and other STIs in July 2021. This article reviews the new recommendations and highlights important updates from the 2015 iteration that are crucial for primary care and community health practice.

Sexually transmissible infection testing guidelines for men who have sex with men

Sexual Health ◽  
2008 ◽  
Vol 5 (2) ◽  
pp. 189 ◽  
Author(s):  
Chris Bourne ◽  
Barry Edwards ◽  
Miranda Shaw ◽  
Andrew Gowers ◽  
Craig Rodgers ◽  
...  
Keyword(s):  
Infection Control ◽  
Sexually Transmitted Infection ◽  
Transmitted Infection ◽  
Sexually Transmitted ◽  
Sex With Men ◽  
Sexually Transmissible Infection ◽  
Transmissible Infection ◽  
Sydney Australia

Since 2002, biennial production of sexually transmissible infection testing guidelines for men who have sex with men has supported sexually transmitted infection control efforts in inner Sydney, Australia.

scholarly journals Febrile Polyarthritis: Should We Think About Disseminated Gonococcal Infection

2021 ◽  
pp. 1-7
Author(s):  
Mariem Ghribi ◽  
Sameh Marzouk ◽  
Abir Derbel ◽  
Mouna Snoussi ◽  
Zouhir Bahloul
Keyword(s):  
Neisseria Gonorrhoeae ◽  
Sexually Transmitted Infection ◽  
The Other ◽  
Gonococcal Infection ◽  
Intravenous Antibiotic ◽  
Transmitted Infection ◽  
Sexually Transmitted ◽  
The Third ◽  
Responsible Agent ◽  
Healthy Female

Gonococcal disease is a sexually transmitted infection. The responsible agent is Neisseria gonorrhoeae. Disseminated gonococcal infection results from blood dissemination of N. gonorrhoeae from its mucosal first site of infection. In our cases, two patients had systematic lupus erythematous, in which one patient developed a dermetitis-arthritis syndrome and the other patient developed a febrile polyarthritis. The third patient was a healthy female who developed a dermetitis-arthritis syndrome. The treatment consisted of intravenous antibiotic and immobilization. The evolution was favorable in all of our cases.

Sign in / Sign up

Export Citation Format

Share Document